NDC product
Nasal Decongestant PE Non-Drowsy Maximum Strength
NDC 63868-144 · CHAIN DRUG MARKETING ASSOCIATION INC
Key facts
| Product NDC | 63868-144 |
|---|---|
| Proprietary name | Nasal Decongestant PE |
| Nonproprietary name | Phenylephrine HCl |
| Substances | PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | CHAIN DRUG MARKETING ASSOCIATION INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Jan 14, 2005 |
| Marketing end | Nov 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory